| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | $1,4300 | +0,70 % | $219,39M | $176,00 | |
| $2,6500 | -3,11 % | $217,47M | $5,000 | |
MFM Aberdeen Municipal Income Fund | $5,3001 | +0,38 % | $217,47M | $210,34K | |
CHCI Comstock Holding Companies, Inc. Class A | $21,0700 | -0,38 % | $217,46M | $22,40K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | $10,0000 | +0,60 % | $217,43M | $12,00 | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | $5,8400 | +0,00 % | $217,14M | $45,77K | |
EXFY Expensify, Inc. Class A Common Stock | $2,3700 | -0,42 % | $217,02M | $378,00 | |
| $64,8700 | +0,08 % | $216,79M | $13,86K | |
IIF Morgan Stanley India Investment Fund, Inc. | $23,0800 | +0,00 % | $216,64M | $46,64K | |
VYGR Voyager Therapeutics, Inc. Common Stock | $3,5200 | +0,29 % | $216,27M | $659,00 | |
MITT TPG Mortgage Investment Trust, Inc. | $6,7900 | -0,15 % | $216,26M | $124,28K | |
| $1,6400 | +3,80 % | $215,73M | $31,00 | |
PEPG PepGen Inc. Common Stock | $3,1100 | +0,00 % | $215,39M | $7,37K | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,6700 | +0,00 % | $215,12M | $827,21K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | $10,5150 | -0,05 % | $214,97M | $107,00 | |
